Clade Therapeutics is a seed-stage cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located at Kendall Square’s LaunchLabs, was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.